UF launches CHAMP program for overweight asthmatic children – The Independent Florida Alligator

UF launches CHAMP program for overweight asthmatic children
The Independent Florida Alligator
The UF Childhood Health and Asthma Management Program (CHAMP) will provide strategies for children and their parents to practice healthy behaviors beginning in January. The program, funded by the American Lung Association, will be of no cost to the to …

View full post on asthma – Google News

Arches Health Plan launches mobile health app from Symptomly: Asthma … – MarketWatch

Arches Health Plan launches mobile health app from Symptomly: Asthma
MarketWatch
In the United States there are currently over 25 million Asthmatics, or 1 in every 12 people is suffering from Asthma. Of those, 2.1 million will be admitted to a hospital or emergency room this year. The estimated medical costs for asthmatics patients

and more »

View full post on asthma – Google News

Arches Health Plan launches mobile health app from Symptomly: Asthma … – Insurance News Net

Arches Health Plan launches mobile health app from Symptomly: Asthma
Insurance News Net
SALT LAKE CITY , Sept. 11, 2014 /PRNewswire-USNewswire/ — Arches Health Plan announced today that it has partnered with Symptomly to provide a more integrated care strategy to asthmatic members. In the United States there are currently over 25 …

and more »

View full post on asthma – Google News

Cipla Ltd launches copy of GSK’s top asthma drug in Germany, Sweden – Economic Times


Economic Times

Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times
MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under

View full post on asthma – Google News

India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla launches Serroflo in Germany and Sweden with affordable high quality pharmabiz.com

all 6 news articles »

View full post on asthma – Google News

New study investigating impact of asthma on school children launches today – HealthCanal.com

New study investigating impact of asthma on school children launches today
HealthCanal.com
Asthma affects one in 11 children and young people in the UK. On average, this is two children in every classroom. Today scientists in East London are launching a new study to measure the impact asthma has on school children, with the aim of improving …

and more »

View full post on asthma – Google News